메뉴 건너뛰기




Volumn 167, Issue , 2017, Pages 89-99

Anticancer copper pyridine benzimidazole complexes: ROS generation, biomolecule interactions, and cytotoxicity

Author keywords

Albumin; Anticancer; Copper; DNA; Reactive oxygen species

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; BENZIMIDAZOLE DERIVATIVE; BUFFER; CISPLATIN; COPPER COMPLEX; HUMAN SERUM ALBUMIN; PYRIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; BENZIMIDAZOLE; COORDINATION COMPOUND; COPPER; CYTOTOXIN; DNA;

EID: 85000814899     PISSN: 01620134     EISSN: 18733344     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2016.11.006     Document Type: Article
Times cited : (93)

References (102)
  • 9
    • 0019817450 scopus 로고
    • [9] Mertz, W., Science 213 (1981), 1332–1338.
    • (1981) Science , vol.213 , pp. 1332-1338
    • Mertz, W.1
  • 11
  • 14
    • 85000647304 scopus 로고    scopus 로고
    • Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
    • Available from:, NLM Identifier: NCT00742911
    • [14] Huntsman Cancer Institute; University of Utah, USA, Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver. ClinicalTrials.gov., 2008-2014 Available from: https://clinicaltrials.gov/ct2/show/NCT00742911, NLM Identifier: NCT00742911.
    • (2008) ClinicalTrials.gov.
    • Huntsman Cancer Institute1    University of Utah, USA,2
  • 15
    • 85000599582 scopus 로고    scopus 로고
    • Disulfiram in Recurrent Glioblastoma
    • Available from:, NLM Identifier: NCT02678975
    • [15] Sahlgrenska University Hospital, Sweden, Disulfiram in Recurrent Glioblastoma. ClinicalTrials.gov., 2016 Available from: https://clinicaltrials.gov/ct2/show/NCT02678975, NLM Identifier: NCT02678975.
    • (2016) ClinicalTrials.gov.
    • Sahlgrenska University Hospital, Sweden,1
  • 16
    • 85000365038 scopus 로고    scopus 로고
    • Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
    • Available from:, NLM Identifier: NCT01907165
    • [16] Washington University School of Medicine, USA, Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide. ClinicalTrials.gov., 2016 Available from: https://clinicaltrials.gov/ct2/show/NCT01907165, NLM Identifier: NCT01907165.
    • (2016) ClinicalTrials.gov.
    • Washington University School of Medicine, USA,1
  • 17
    • 85000476921 scopus 로고    scopus 로고
    • Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform (GLIODIS)
    • Available from:, NLM Identifier: NCT01777919
    • [17] Olympion Medical Center, Patras, Greece, Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform (GLIODIS). ClinicalTrials.gov., 2016 Available from: https://clinicaltrials.gov/ct2/show/NCT01777919, NLM Identifier: NCT01777919.
    • (2016) ClinicalTrials.gov.
    • Olympion Medical Center, Patras, Greece,1
  • 52
    • 33845556505 scopus 로고
    • [52] Creutz, C., Inorg. Chem. 20 (1981), 4449–4452.
    • (1981) Inorg. Chem. , vol.20 , pp. 4449-4452
    • Creutz, C.1
  • 55
    • 0028009789 scopus 로고
    • [55] Chu, G., J. Biol. Chem. 269 (1994), 787–790.
    • (1994) J. Biol. Chem. , vol.269 , pp. 787-790
    • Chu, G.1
  • 58
    • 0003397410 scopus 로고
    • Transition Ion Electron Paramagnetic Resonance
    • Clarendon Press
    • [58] Pilbrow, J.R., Transition Ion Electron Paramagnetic Resonance. 1990, Clarendon Press.
    • (1990)
    • Pilbrow, J.R.1
  • 63
    • 85000490308 scopus 로고
    • [63] Kratz, F., VCH, 1993, 391–429.
    • (1993) VCH , pp. 391-429
    • Kratz, F.1
  • 87
  • 90
    • 0018263443 scopus 로고
    • [90] Fridovich, I., Science 201 (1978), 875–880.
    • (1978) Science , vol.201 , pp. 875-880
    • Fridovich, I.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.